Navigation Links
Genomic Health to Announce First Quarter 2012 Financial Results and Host Conference Call on Wednesday, May 2, 2012
Date:4/25/2012

DX® breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS).  In addition to this widely adopted test, Genomic Health provides the Oncotype DX colon cancer test, the first multigene expression test developed for the assessment of risk of recurrence in patients with stage II disease.  As of December 31, 2011, more than 10,000 physicians in over 65 countries had ordered more than 265,000 Oncotype DX tests.  Genomic Health has a robust pipeline focused on developing tests to optimize the treatment of prostate and renal cell cancers, as well as additional treatment decisions in breast and colon cancers.  In February, the company announced plans to form a new wholly owned genetics subsidiary to focus on the commercial applications of the human genome, with the goal of making commercial services available to physicians and patients in 2013.  The company is based in Redwood City, California with European headquarters in Geneva, Switzerland.  For more information, please visit, www.GenomicHealth.com.  To learn more about Oncotype DX tests, visit: www.OncotypeDX.com and www.mybreastcancertreatment.org

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the attributes and focus of the company's product pipeline, the ability of the company to develop additional tests in
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Empire Genomics Chooses Funakoshi as Japan Distributor
2. CrystalGenomics Announces Positive Results from Phase 2b Osteoarthritis Study of CG100649
3. Everist Genomics Develops Worlds First Comprehensive Companion Diagnostics and Prognostics Portfolio for Early Diagnosis and Improved Treatment of Colorectal Cancer
4. Rubicon Genomics Selects Velesco to Manufacture its TransPLEX® RNA Amplification Kits for Clinical Diagnostic Use
5. Compendia Bioscience and H3 Biomedicine Announce Strategic Collaboration to Apply Cancer Genomics to Discover and Develop Next Generation Cancer Therapeutics
6. Genomic Health Announces Formation of New Genetics Subsidiary
7. Synthetic Genomics, Inc. and Integrated DNA Technologies, Inc. Sign Agreement to Manufacture, Market, and Commercialize Small Synthetic Gene Products Using SGI Technology
8. Smartphone Technology Meets Personalized Medicine in Everist Genomics CardioDefender Diagnostic System
9. Genomic Health Announces Initiation of Clinical Validation Study of Prostate Cancer Test; Acceleration of Next Generation Sequencing Program
10. AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
11. AbGenomics International, Inc. Regains Global Rights to AbGn-168H from Boehringer Ingelheim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... SAN FRANCISCO , July 31, 2014 /PRNewswire/ ... ) and Aspira Scientific ( Milpitas, California ... joint venture to develop and commercialize new fluorination ... biologically active molecules has benefited from the use ... metabolism, and combine lipophilicity with polarity to improve ...
(Date:7/31/2014)... For the first time, cardiac surgeons, medical ... the SynCardia temporary Total Artificial Heart in a peer ... the Journal of Visualized Experiments website. ... the SynCardia Total Artificial Heart implantation   goo.gl/2OZyKW ... the SynCardia Total Artificial Heart," a July 18, 2014 ...
(Date:7/31/2014)... July 31, 2014 The Galien Foundation today ... Galien USA Awards. The Prix ... and recognizes the technical, scientific and clinical research skills ... This year brings the highest number of nominees since ... . Nominees include biomedical products across three categories ...
Breaking Medicine Technology:Catylix, Inc. and Aspira Scientific Announce Joint Venture to Commercialize New Fluorination Technologies 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 2How to Implant the SynCardia Total Artificial Heart Detailed in Peer Reviewed Paper and Matching Video 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 2The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 3The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 4The Galien Foundation Announces 2014 Prix Galien USA Nominees for "Best Biotechnology Product," "Best Pharmaceutical Agent," and "Best Medical Technology" 5
... ... ... EST Q It,s an interesting time, so we really are eager to talk to you about,especially ... I,d love your overall assessment from -- of what,s,been happening on the Hill, like Pelosi,s leadership and ...
... Data from 11 PROCRIT(R) (Epoetin alfa),studies will be presented at the ... - 11, 2007., The data will provide ... blood supply of limiting the use of ... chemotherapy-induced anemia (CIA); -- the use of PROCRIT in extended ...
Cached Medicine Technology:Interview of the Vice President 2Interview of the Vice President 3Interview of the Vice President 4Interview of the Vice President 5Interview of the Vice President 6Interview of the Vice President 7Interview of the Vice President 8Interview of the Vice President 9Interview of the Vice President 10Interview of the Vice President 11Interview of the Vice President 12Interview of the Vice President 13Interview of the Vice President 14Interview of the Vice President 15Interview of the Vice President 16PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 2PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 3PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 4PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 5PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 6PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 7PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 8PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 9
(Date:7/31/2014)... Andrie, Inc. V. Dept. of Treasury, Mich. ... Court has made the determination that a purchaser of tangible ... taxpayer was unable to prove during an audit that ... the Court of Appeals decision on whether a purchaser bears ... for purchases from Michigan sellers. The Court states “in order ...
(Date:7/31/2014)... Dr. Parsa Mohebi presented his groundbreaking technique ... audience of international hair restoration surgeons. His technique known ... of a patient’s hair transplant scar. Patients are extremely ... detectable in most cases. , The doctor explained ... of donor wound closure known as Trichophytic Closure, “Partial ...
(Date:7/31/2014)... Hudson County, NJ (PRWEB) July 31, 2014 ... that a leading gastroenterologist, Dr. Masood Rizvi, has ... system welcomes Dr. Rizvi to the community. Hundreds ... Health Medical Group, a comprehensive network of top ... wide range of specialties. This latest acquisition represents ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Etymotic ... announced a new sponsorship of the DrumLine Battle® ... are Etymotic’s hearing protection products ETY•Plugs® and Music•PRO® ... against the harmful effects of high-level sound. Etymotic ... sponsorship at the Drum Corps International Championships on ...
(Date:7/31/2014)... Most mommy blogs are simple family journals, confessionals ... attract all mothers from all walks of life. ... its high fashion or child rearing. When Felicia Blendermann ... Internet was so segmented. “I found myself visiting various ... then search Google to get information on another. At ...
Breaking Medicine News(10 mins):Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 2Health News:Taxpayer Failing To Prove Sales Tax Was Paid At Time Of Purchase Results In Use Tax Due 3Health News:Novel Technique in Wound Closure Delivers More Discreet Results in Hair Transplant Patients 2Health News:Dr. Rizvi Joins CarePoint Health Medical Group 2Health News:Etymotic Research Becomes The Official Hearing Protection Sponsor Of DrumLine Battle 2Health News:Mommylish Launches Its Website 2
... , March 18 In its 21-year history, under ... SRLA has trained more than 40,000 teenagers from 170 schools in ... mile Los Angeles Marathon. On March 21 , 2,800 SRLA ... While running is the core activity of the program, SRLA,s mission ...
... Meetings on C-SPAN; Held Private Health Care Discussions with Vice President Biden, HHS Secretary Sebelius, Speaker Pelosi, Majority Leader Reid and Union Officials , ... , ... ... ...
... Shines Spotlight on Need for New Meat Regulations , ... , , ... ... WASHINGTON , March 18 S.T.O.P. - Safe Tables Our Priority and ...
... the workplace can be a health hazard for people over ... of the Journals of Gerontology Series B: Psychological ... A team of researchers found that job insecurity increased the ... in Cook County, IL. Over time, men reacted with greater ...
... Improving Health and ... ... provider, is pleased to announce that U.S. Army Sergeant Andrew Cottam recently received ... more than 600 clinics throughout 42 states., , , , ,Cottam, an Army recruiter in ...
... promote well-being in pregnancy, researcher says , THURSDAY, March 18 ... that a baby will develop asthma, a new study finds. ... but animal studies suggest that prenatal stress can influence the ... is also known that asthma is most prevalent in inner ...
Cached Medicine News:Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 2Health News:Students Run LA Takes 40,000 Students Across the Marathon Finish Line Over Past 21 Years 3Health News:JW Sues HHS to Obtain President's Closed-Door Health Care Meeting Docs 2Health News:JW Sues HHS to Obtain President's Closed-Door Health Care Meeting Docs 3Health News:JW Sues HHS to Obtain President's Closed-Door Health Care Meeting Docs 4Health News:Victims of Contaminated Meat Call on USDA to Address Deadly Pathogens 2Health News:Victims of Contaminated Meat Call on USDA to Address Deadly Pathogens 3Health News:Looming unemployment harms older workers' health 2Health News:Massage Envy Performs 20 Millionth Massage 2Health News:Prenatal Stress May Boost Baby's Asthma Risk 2Health News:Prenatal Stress May Boost Baby's Asthma Risk 3
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoTwist is a low profile unipolar permanent pacing lead with a retractable screw. Due to advanced technology VascoTwist 9/60 M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (...
Medicine Products: